View drug registration information details.
| Items | Registration information |
|---|
| ID | 349 |
|---|
| No | 349 |
|---|
| Brand Name | LENVACARE 10 |
|---|
| Ingredients | LENVATINIB 10 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | STORE BELOW 30C |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 30'S |
|---|
| Dispensing Category | Prescription only |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | ANTINEOPLASTIC |
|---|
| Indications | AS MONOTHERAPY FOR THE TREATMENT OF ADULT PATIENTS WITH PROGRESSIVE, LOCALLY ADVANCED OR METASTATIC DIFFERENTIATED THYROIDCARCINIMA, REFRACTORY TO RADIOACTIVE IODINE. AS MONOTHERAPY FOR THE TREATMENT OF ADULT PATIENTS WITH ADVANCED OR UNRESECTABLE HEPATOCELLULAR CARCINOMA WHO HAVE RECEIVED NO PRIOR SYSTEMIC THERAPY |
|---|
| Contraindications | HYPERSENSITIVITY |
|---|
| Side Effects | HYPERTENSION, CARDIAC DYSFUNCTION, HEPATOTOXICITY, DIARRHEA, HYPOCALCEMIA, WOUND HEALING COMPLICATION |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | CAPSULE CONTAINS WHITE POWDER |
|---|
| Note | |
|---|
| License Owner | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Manufacturer | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Country | LAO PDR |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | - |
|---|
| FDD Registration No | 03 L 0851/21 |
|---|
| FDD Registration Date | 2025-02-20 |
|---|
| Expiry Date | 2030-02-19 |
|---|
Back to drug list
|
